Global Coagulation Factor IX Market Growth 2025-2031

October 2025 | 89 pages | ID: G0F20CF5E87BEN
LP Information

Abstracts

The global Coagulation Factor IX market size is predicted to grow from US$ 406 million in 2025 to US$ 577 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the ?Coagulation Factor IX Industry Forecast? looks at past sales and reviews total world Coagulation Factor IX sales in 2024, providing a comprehensive analysis by region and market sector of projected Coagulation Factor IX sales for 2025 through 2031. With Coagulation Factor IX sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coagulation Factor IX industry.

This Insight Report provides a comprehensive analysis of the global Coagulation Factor IX landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Coagulation Factor IX portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Coagulation Factor IX market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coagulation Factor IX and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coagulation Factor IX.

This report presents a comprehensive overview, market shares, and growth opportunities of Coagulation Factor IX market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Coagulation Factor IX (Plasma Derived)
• Coagulation Factor IX (Recombinant)

Segmentation by Application:

• Adult
• Kids

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pfizer
• CSL Behring
• Grifols
• Novo Nordisk
• Bioverativ
• Sanquin
• Takeda
• Baxter
• Aptevo

Key Questions Addressed in this Report

What is the 10-year outlook for the global Coagulation Factor IX market?
What factors are driving Coagulation Factor IX market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Coagulation Factor IX market opportunities vary by end market size?
How does Coagulation Factor IX break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Coagulation Factor IX Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Coagulation Factor IX by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Coagulation Factor IX by Country/Region, 2020, 2024 & 2031
2.2 Coagulation Factor IX Segment by Type
  2.2.1 Coagulation Factor IX (Plasma Derived)
  2.2.2 Coagulation Factor IX (Recombinant)
2.3 Coagulation Factor IX Sales by Type
  2.3.1 Global Coagulation Factor IX Sales Market Share by Type (2020-2025)
  2.3.2 Global Coagulation Factor IX Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Coagulation Factor IX Sale Price by Type (2020-2025)
2.4 Coagulation Factor IX Segment by Application
  2.4.1 Adult
  2.4.2 Kids
2.5 Coagulation Factor IX Sales by Application
  2.5.1 Global Coagulation Factor IX Sale Market Share by Application (2020-2025)
  2.5.2 Global Coagulation Factor IX Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Coagulation Factor IX Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Coagulation Factor IX Breakdown Data by Company
  3.1.1 Global Coagulation Factor IX Annual Sales by Company (2020-2025)
  3.1.2 Global Coagulation Factor IX Sales Market Share by Company (2020-2025)
3.2 Global Coagulation Factor IX Annual Revenue by Company (2020-2025)
  3.2.1 Global Coagulation Factor IX Revenue by Company (2020-2025)
  3.2.2 Global Coagulation Factor IX Revenue Market Share by Company (2020-2025)
3.3 Global Coagulation Factor IX Sale Price by Company
3.4 Key Manufacturers Coagulation Factor IX Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Coagulation Factor IX Product Location Distribution
  3.4.2 Players Coagulation Factor IX Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR COAGULATION FACTOR IX BY GEOGRAPHIC REGION

4.1 World Historic Coagulation Factor IX Market Size by Geographic Region (2020-2025)
  4.1.1 Global Coagulation Factor IX Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Coagulation Factor IX Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Coagulation Factor IX Market Size by Country/Region (2020-2025)
  4.2.1 Global Coagulation Factor IX Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Coagulation Factor IX Annual Revenue by Country/Region (2020-2025)
4.3 Americas Coagulation Factor IX Sales Growth
4.4 APAC Coagulation Factor IX Sales Growth
4.5 Europe Coagulation Factor IX Sales Growth
4.6 Middle East & Africa Coagulation Factor IX Sales Growth

5 AMERICAS

5.1 Americas Coagulation Factor IX Sales by Country
  5.1.1 Americas Coagulation Factor IX Sales by Country (2020-2025)
  5.1.2 Americas Coagulation Factor IX Revenue by Country (2020-2025)
5.2 Americas Coagulation Factor IX Sales by Type (2020-2025)
5.3 Americas Coagulation Factor IX Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Coagulation Factor IX Sales by Region
  6.1.1 APAC Coagulation Factor IX Sales by Region (2020-2025)
  6.1.2 APAC Coagulation Factor IX Revenue by Region (2020-2025)
6.2 APAC Coagulation Factor IX Sales by Type (2020-2025)
6.3 APAC Coagulation Factor IX Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Coagulation Factor IX by Country
  7.1.1 Europe Coagulation Factor IX Sales by Country (2020-2025)
  7.1.2 Europe Coagulation Factor IX Revenue by Country (2020-2025)
7.2 Europe Coagulation Factor IX Sales by Type (2020-2025)
7.3 Europe Coagulation Factor IX Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Coagulation Factor IX by Country
  8.1.1 Middle East & Africa Coagulation Factor IX Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Coagulation Factor IX Revenue by Country (2020-2025)
8.2 Middle East & Africa Coagulation Factor IX Sales by Type (2020-2025)
8.3 Middle East & Africa Coagulation Factor IX Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Coagulation Factor IX
10.3 Manufacturing Process Analysis of Coagulation Factor IX
10.4 Industry Chain Structure of Coagulation Factor IX

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Coagulation Factor IX Distributors
11.3 Coagulation Factor IX Customer

12 WORLD FORECAST REVIEW FOR COAGULATION FACTOR IX BY GEOGRAPHIC REGION

12.1 Global Coagulation Factor IX Market Size Forecast by Region
  12.1.1 Global Coagulation Factor IX Forecast by Region (2026-2031)
  12.1.2 Global Coagulation Factor IX Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Coagulation Factor IX Forecast by Type (2026-2031)
12.7 Global Coagulation Factor IX Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Coagulation Factor IX Product Portfolios and Specifications
  13.1.3 Pfizer Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 CSL Behring
  13.2.1 CSL Behring Company Information
  13.2.2 CSL Behring Coagulation Factor IX Product Portfolios and Specifications
  13.2.3 CSL Behring Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 CSL Behring Main Business Overview
  13.2.5 CSL Behring Latest Developments
13.3 Grifols
  13.3.1 Grifols Company Information
  13.3.2 Grifols Coagulation Factor IX Product Portfolios and Specifications
  13.3.3 Grifols Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Grifols Main Business Overview
  13.3.5 Grifols Latest Developments
13.4 Novo Nordisk
  13.4.1 Novo Nordisk Company Information
  13.4.2 Novo Nordisk Coagulation Factor IX Product Portfolios and Specifications
  13.4.3 Novo Nordisk Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Novo Nordisk Main Business Overview
  13.4.5 Novo Nordisk Latest Developments
13.5 Bioverativ
  13.5.1 Bioverativ Company Information
  13.5.2 Bioverativ Coagulation Factor IX Product Portfolios and Specifications
  13.5.3 Bioverativ Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Bioverativ Main Business Overview
  13.5.5 Bioverativ Latest Developments
13.6 Sanquin
  13.6.1 Sanquin Company Information
  13.6.2 Sanquin Coagulation Factor IX Product Portfolios and Specifications
  13.6.3 Sanquin Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Sanquin Main Business Overview
  13.6.5 Sanquin Latest Developments
13.7 Takeda
  13.7.1 Takeda Company Information
  13.7.2 Takeda Coagulation Factor IX Product Portfolios and Specifications
  13.7.3 Takeda Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Takeda Main Business Overview
  13.7.5 Takeda Latest Developments
13.8 Baxter
  13.8.1 Baxter Company Information
  13.8.2 Baxter Coagulation Factor IX Product Portfolios and Specifications
  13.8.3 Baxter Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Baxter Main Business Overview
  13.8.5 Baxter Latest Developments
13.9 Aptevo
  13.9.1 Aptevo Company Information
  13.9.2 Aptevo Coagulation Factor IX Product Portfolios and Specifications
  13.9.3 Aptevo Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Aptevo Main Business Overview
  13.9.5 Aptevo Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Coagulation Factor IX Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Coagulation Factor IX Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Coagulation Factor IX (Plasma Derived)
Table 4. Major Players of Coagulation Factor IX (Recombinant)
Table 5. Global Coagulation Factor IX Sales by Type (2020-2025) & (K Units)
Table 6. Global Coagulation Factor IX Sales Market Share by Type (2020-2025)
Table 7. Global Coagulation Factor IX Revenue by Type (2020-2025) & ($ million)
Table 8. Global Coagulation Factor IX Revenue Market Share by Type (2020-2025)
Table 9. Global Coagulation Factor IX Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Coagulation Factor IX Sale by Application (2020-2025) & (K Units)
Table 11. Global Coagulation Factor IX Sale Market Share by Application (2020-2025)
Table 12. Global Coagulation Factor IX Revenue by Application (2020-2025) & ($ million)
Table 13. Global Coagulation Factor IX Revenue Market Share by Application (2020-2025)
Table 14. Global Coagulation Factor IX Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Coagulation Factor IX Sales by Company (2020-2025) & (K Units)
Table 16. Global Coagulation Factor IX Sales Market Share by Company (2020-2025)
Table 17. Global Coagulation Factor IX Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Coagulation Factor IX Revenue Market Share by Company (2020-2025)
Table 19. Global Coagulation Factor IX Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Coagulation Factor IX Producing Area Distribution and Sales Area
Table 21. Players Coagulation Factor IX Products Offered
Table 22. Coagulation Factor IX Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Coagulation Factor IX Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Coagulation Factor IX Sales Market Share Geographic Region (2020-2025)
Table 27. Global Coagulation Factor IX Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Coagulation Factor IX Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Coagulation Factor IX Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Coagulation Factor IX Sales Market Share by Country/Region (2020-2025)
Table 31. Global Coagulation Factor IX Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Coagulation Factor IX Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Coagulation Factor IX Sales by Country (2020-2025) & (K Units)
Table 34. Americas Coagulation Factor IX Sales Market Share by Country (2020-2025)
Table 35. Americas Coagulation Factor IX Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Coagulation Factor IX Sales by Type (2020-2025) & (K Units)
Table 37. Americas Coagulation Factor IX Sales by Application (2020-2025) & (K Units)
Table 38. APAC Coagulation Factor IX Sales by Region (2020-2025) & (K Units)
Table 39. APAC Coagulation Factor IX Sales Market Share by Region (2020-2025)
Table 40. APAC Coagulation Factor IX Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Coagulation Factor IX Sales by Type (2020-2025) & (K Units)
Table 42. APAC Coagulation Factor IX Sales by Application (2020-2025) & (K Units)
Table 43. Europe Coagulation Factor IX Sales by Country (2020-2025) & (K Units)
Table 44. Europe Coagulation Factor IX Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Coagulation Factor IX Sales by Type (2020-2025) & (K Units)
Table 46. Europe Coagulation Factor IX Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Coagulation Factor IX Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Coagulation Factor IX Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Coagulation Factor IX Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Coagulation Factor IX Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Coagulation Factor IX
Table 52. Key Market Challenges & Risks of Coagulation Factor IX
Table 53. Key Industry Trends of Coagulation Factor IX
Table 54. Coagulation Factor IX Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Coagulation Factor IX Distributors List
Table 57. Coagulation Factor IX Customer List
Table 58. Global Coagulation Factor IX Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Coagulation Factor IX Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Coagulation Factor IX Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Coagulation Factor IX Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Coagulation Factor IX Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Coagulation Factor IX Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Coagulation Factor IX Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Coagulation Factor IX Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Coagulation Factor IX Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Coagulation Factor IX Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Coagulation Factor IX Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Coagulation Factor IX Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Coagulation Factor IX Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Coagulation Factor IX Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Coagulation Factor IX Product Portfolios and Specifications
Table 74. Pfizer Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. CSL Behring Basic Information, Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Behring Coagulation Factor IX Product Portfolios and Specifications
Table 79. CSL Behring Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. CSL Behring Main Business
Table 81. CSL Behring Latest Developments
Table 82. Grifols Basic Information, Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 83. Grifols Coagulation Factor IX Product Portfolios and Specifications
Table 84. Grifols Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Grifols Main Business
Table 86. Grifols Latest Developments
Table 87. Novo Nordisk Basic Information, Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 88. Novo Nordisk Coagulation Factor IX Product Portfolios and Specifications
Table 89. Novo Nordisk Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Novo Nordisk Main Business
Table 91. Novo Nordisk Latest Developments
Table 92. Bioverativ Basic Information, Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 93. Bioverativ Coagulation Factor IX Product Portfolios and Specifications
Table 94. Bioverativ Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Bioverativ Main Business
Table 96. Bioverativ Latest Developments
Table 97. Sanquin Basic Information, Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanquin Coagulation Factor IX Product Portfolios and Specifications
Table 99. Sanquin Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Sanquin Main Business
Table 101. Sanquin Latest Developments
Table 102. Takeda Basic Information, Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 103. Takeda Coagulation Factor IX Product Portfolios and Specifications
Table 104. Takeda Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Takeda Main Business
Table 106. Takeda Latest Developments
Table 107. Baxter Basic Information, Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 108. Baxter Coagulation Factor IX Product Portfolios and Specifications
Table 109. Baxter Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Baxter Main Business
Table 111. Baxter Latest Developments
Table 112. Aptevo Basic Information, Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 113. Aptevo Coagulation Factor IX Product Portfolios and Specifications
Table 114. Aptevo Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Aptevo Main Business
Table 116. Aptevo Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Coagulation Factor IX
Figure 2. Coagulation Factor IX Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Coagulation Factor IX Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Coagulation Factor IX Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Coagulation Factor IX Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Coagulation Factor IX Sales Market Share by Country/Region (2024)
Figure 10. Coagulation Factor IX Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Coagulation Factor IX (Plasma Derived)
Figure 12. Product Picture of Coagulation Factor IX (Recombinant)
Figure 13. Global Coagulation Factor IX Sales Market Share by Type in 2025
Figure 14. Global Coagulation Factor IX Revenue Market Share by Type (2020-2025)
Figure 15. Coagulation Factor IX Consumed in Adult
Figure 16. Global Coagulation Factor IX Market: Adult (2020-2025) & (K Units)
Figure 17. Coagulation Factor IX Consumed in Kids
Figure 18. Global Coagulation Factor IX Market: Kids (2020-2025) & (K Units)
Figure 19. Global Coagulation Factor IX Sale Market Share by Application (2024)
Figure 20. Global Coagulation Factor IX Revenue Market Share by Application in 2025
Figure 21. Coagulation Factor IX Sales by Company in 2025 (K Units)
Figure 22. Global Coagulation Factor IX Sales Market Share by Company in 2025
Figure 23. Coagulation Factor IX Revenue by Company in 2025 ($ millions)
Figure 24. Global Coagulation Factor IX Revenue Market Share by Company in 2025
Figure 25. Global Coagulation Factor IX Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Coagulation Factor IX Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Coagulation Factor IX Sales 2020-2025 (K Units)
Figure 28. Americas Coagulation Factor IX Revenue 2020-2025 ($ millions)
Figure 29. APAC Coagulation Factor IX Sales 2020-2025 (K Units)
Figure 30. APAC Coagulation Factor IX Revenue 2020-2025 ($ millions)
Figure 31. Europe Coagulation Factor IX Sales 2020-2025 (K Units)
Figure 32. Europe Coagulation Factor IX Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Coagulation Factor IX Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Coagulation Factor IX Revenue 2020-2025 ($ millions)
Figure 35. Americas Coagulation Factor IX Sales Market Share by Country in 2025
Figure 36. Americas Coagulation Factor IX Revenue Market Share by Country (2020-2025)
Figure 37. Americas Coagulation Factor IX Sales Market Share by Type (2020-2025)
Figure 38. Americas Coagulation Factor IX Sales Market Share by Application (2020-2025)
Figure 39. United States Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Coagulation Factor IX Sales Market Share by Region in 2025
Figure 44. APAC Coagulation Factor IX Revenue Market Share by Region (2020-2025)
Figure 45. APAC Coagulation Factor IX Sales Market Share by Type (2020-2025)
Figure 46. APAC Coagulation Factor IX Sales Market Share by Application (2020-2025)
Figure 47. China Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 51. India Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Coagulation Factor IX Sales Market Share by Country in 2025
Figure 55. Europe Coagulation Factor IX Revenue Market Share by Country (2020-2025)
Figure 56. Europe Coagulation Factor IX Sales Market Share by Type (2020-2025)
Figure 57. Europe Coagulation Factor IX Sales Market Share by Application (2020-2025)
Figure 58. Germany Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 59. France Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Coagulation Factor IX Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Coagulation Factor IX Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Coagulation Factor IX Sales Market Share by Application (2020-2025)
Figure 66. Egypt Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Coagulation Factor IX Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Coagulation Factor IX in 2025
Figure 72. Manufacturing Process Analysis of Coagulation Factor IX
Figure 73. Industry Chain Structure of Coagulation Factor IX
Figure 74. Channels of Distribution
Figure 75. Global Coagulation Factor IX Sales Market Forecast by Region (2026-2031)
Figure 76. Global Coagulation Factor IX Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Coagulation Factor IX Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Coagulation Factor IX Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Coagulation Factor IX Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Coagulation Factor IX Revenue Market Share Forecast by Application (2026-2031)